Source link : https://www.newshealth.biz/health-news/first-tavr-for-aortic-regurgitation-moves-to-phase-3-trial/
WASHINGTON — A phase 3 randomized trial will soon begin for the first transcatheter aortic valve replacement (TAVR) device for the treatment of aortic valve regurgitation after promising results in a 2-year initial study. If this novel option performs as well as surgical aortic valve replacement (SAVR) in the coming trial, the regurgitation-specific valve “will […]
Author : News Health
Publish date : 2024-11-13 13:30:11
Copyright for syndicated content belongs to the linked Source.
inHealth